BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12019727)

  • 21. Vancomycin-resistant enterococci: consequences for therapy and infection control.
    Mascini EM; Bonten MJ
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():43-56. PubMed ID: 15953021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA; Shay DK; Patel P; Tacsa L; Maloney SA; Jarvis WR; Wormser GP
    Arch Intern Med; 1996 Jul; 156(13):1458-62. PubMed ID: 8678715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin-resistant enterococci: an emerging health problem.
    Whittle J; Queenan E
    Pa Med; 1997 Oct; 100(10):30-2. PubMed ID: 9509872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece.
    Kalocheretis P; Baimakou E; Zerbala S; Papaparaskevas J; Makriniotou I; Tassios PT; Iatrou C; Kouskouni E; Zerva L
    J Antimicrob Chemother; 2004 Dec; 54(6):1031-4. PubMed ID: 15498878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic and genetic characterization of vancomycin-resistant enterococci from hospitalized humans and from poultry in Korea.
    Jung WK; Hong SK; Lim JY; Lim SK; Kwon NH; Kim JM; Koo HC; Kim SH; Seo KS; Ike Y; Tanimoto K; Park YH
    FEMS Microbiol Lett; 2006 Jul; 260(2):193-200. PubMed ID: 16842344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vancomycin resistant enterococci in the Netherlands].
    Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of vancomycin-resistant enterococci in Europe.
    Schouten MA; Hoogkamp-Korstanje JA; Meis JF; Voss A;
    Eur J Clin Microbiol Infect Dis; 2000 Nov; 19(11):816-22. PubMed ID: 11152305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
    Kuwahara K; Hanaki H; Hiramatsu K
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):182-5. PubMed ID: 10088368
    [No Abstract]   [Full Text] [Related]  

  • 30. Vancomycin-resistant enterococci (VRE) in meat and environmental samples.
    Messi P; Guerrieri E; de Niederhäusern S; Sabia C; Bondi M
    Int J Food Microbiol; 2006 Mar; 107(2):218-22. PubMed ID: 16280183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Typing of vancomycin-resistant Enterococcus faecium strains in a cohort of patients in an Italian intensive care Unit.
    Lambiase A; Del Pezzo M; Piazza O; Petagna C; De Luca C; Rossano F
    Infection; 2007 Dec; 35(6):428-33. PubMed ID: 18034209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran.
    Askarian M; Afkhamzadeh R; Monabbati A; Daxboeck F; Assadian O
    Int J Infect Dis; 2008 Mar; 12(2):171-5. PubMed ID: 17855141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vancomycin-resistant enterococci . Work Group Hospital Infection Epidemiology].
    Endtz HP; van Belkum A; van Duin J
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):108-9. PubMed ID: 9036340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycin-resistant enterococci.
    D'Agata EM; Webb G; Horn M
    J Infect Dis; 2005 Dec; 192(11):2004-11. PubMed ID: 16267774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):289-91. PubMed ID: 8598826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM; Sun J; Iwen PC; Rupp ME
    Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colonization with vancomycin-resistant enterococci (VRE) in intensive care unit patients in Cordoba City, Argentina.
    Littvik AM; López TN; González SE; Fernández CM; Pavan JV
    Rev Argent Microbiol; 2006; 38(1):28-30. PubMed ID: 16784130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and molecular characterization of vancomycin resistant Enterococci isolates in India.
    Khudaier BY; Tewari R; Shafiani S; Sharma M; Emmanuel R; Sharma M; Taneja N
    Scand J Infect Dis; 2007; 39(8):662-70. PubMed ID: 17654341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies.
    Hoshuyama T; Moriguchi H; Muratani T; Matsumoto T
    J Infect Chemother; 2008 Oct; 14(5):354-60. PubMed ID: 18936888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.
    McDonald LC; Kuehnert MJ; Tenover FC; Jarvis WR
    Emerg Infect Dis; 1997; 3(3):311-7. PubMed ID: 9284375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.